The Impact of Opioids in Coronary Heart Disease (MIOP/TRAPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02740621|
Recruitment Status : Completed
First Posted : April 15, 2016
Last Update Posted : April 11, 2018
In this study, the risk of opioid medications on coronary heart disease in adults is investigated. Patients with the necessity of a coronary angiography and control patients with a non-cardiac disease of the same hospital are inquired with a standardized questionnaire about demographic and clinical risk factors for heart attack. An impact of opioid medications on coronary heart disease is hypothesised (MIOP).
In addition, all patients with coronary angiography should be consulted twice (after 3 and 6 months) to find out how many of these patients have developed a refractory angina pectoris (TRAPS).
|Condition or disease|
|Coronary Heart Disease|
|Study Type :||Observational|
|Actual Enrollment :||750 participants|
|Official Title:||Evaluation of Past Medications in Patients With Coronary Heart Disease and Patients Hospitalized for a Non-cardiac Reason|
|Actual Study Start Date :||January 2016|
|Actual Primary Completion Date :||January 2017|
|Actual Study Completion Date :||August 2017|
Patients with coronary heart disease
coronary angiography with finding coronary heart disease currently no cancer 40 years or older
coronary angiography with exclusion coronary heart disease or other patients with non-cardiac diseases currently no cancer 40 years or older
- Number of patients with opioid treatment (WHO II/ WHO III) within the last 10 years before present hospitalization, Interview with standardized CRF [ Time Frame: 20 minutes ]
Standardized assessment of opioid medications taken before hospital admission to evaluate the impact of opioids in coronary heart disease.
Exact doses, substances and intake habits are inquired.
- Number of patients with refractory angina pectoris, Interview with standardized CRF [ Time Frame: 30 minutes ]
Standardized assessment of angina pectoris symptoms and treatments to evaluate a refractory angina pectoris.
Changes of their medications are inquired twice.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02740621
|Bergmannsheil department of pain therapy|
|Bochum, Nordrhein-Westfalen, Germany, 44789|